Commitment to Research

CARING, Double and triple concentrated Nicardipine, Investigator Initiated Trial
PI: David Z. Wang, DO

TNKilas, Tenecteplase for Ischemic Lacunar Stroke, Investigator Initiated Trial.
PI: David Z. Wang, DO

The Insulin Resistance Intervention After Stroke Trial (IRIS), A randomized, placebo-controlled trial of pioglitazone, compared with placebo, for prevention of recurrent stroke and myocardial infarction after non-embolic ischemic stroke.
PI: David Z. Wang, DO

DESMOTEPLASE (INN) IN ACUTE ISCHEMIC STROKE, (DIAS 2), A prospective, randomized, double-blind, placebo-controlled, single bous, multinational, multi-center, parallel group, dose ranging study of INN in the indication of acute ischemic stroke.
PI: Arun Talkad, MD

To learn more about our research programs please call (309) 655-3821.